STIPO, MARIA ELENA
 Distribuzione geografica
Continente #
EU - Europa 1.061
NA - Nord America 235
AS - Asia 80
OC - Oceania 1
SA - Sud America 1
Totale 1.378
Nazione #
IT - Italia 889
US - Stati Uniti d'America 235
IE - Irlanda 69
SE - Svezia 66
CN - Cina 63
DE - Germania 13
IN - India 11
FI - Finlandia 7
BE - Belgio 4
FR - Francia 3
CH - Svizzera 2
GB - Regno Unito 2
HK - Hong Kong 2
NL - Olanda 2
RU - Federazione Russa 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
IR - Iran 1
KZ - Kazakistan 1
PT - Portogallo 1
TR - Turchia 1
Totale 1.378
Città #
Milan 78
Dublin 69
Chandler 63
Rome 55
Nyköping 44
Naples 37
Turin 31
Beijing 30
Trieste 24
Genoa 22
Ashburn 19
Palermo 14
Bari 13
Dearborn 12
Catania 11
Jacksonville 11
Messina 11
Ann Arbor 10
Bremen 10
Princeton 10
Des Moines 9
Florence 9
Medford 9
Verona 9
Brescia 8
Parma 8
Prato 8
Cambridge 7
Bergamo 6
New York 6
Syracuse 6
Venice 6
Hyderabad 5
Jinan 5
Pune 5
Sarno 5
Aversa 4
Barletta 4
Brussels 4
Cagliari 4
Cassano delle Murge 4
Castel San Giorgio 4
Gragnano 4
Iesi 4
Lucca 4
Modena 4
Modugno 4
Ponte San Pietro 4
Porcia 4
Shenyang 4
Casavatore 3
Castel Rozzone 3
Castellammare di Stabia 3
Frosinone 3
Mogliano Veneto 3
Monza 3
Nanjing 3
Nepi 3
Pescara 3
San Giovanni in Persiceto 3
San Mateo 3
Tianjin 3
Udine 3
Aci Castello 2
Airola 2
Ancona 2
Angri 2
Ascoli Piceno 2
Avellino 2
Benevento 2
Biccari 2
Bitonto 2
Bologna 2
Bosco Marengo 2
Brindisi 2
Carbonara di Nola 2
Carobbio degli Angeli 2
Casoria 2
Castegnero 2
Castelbuono 2
Castenaso 2
Ceprano 2
Cerignola 2
Changsha 2
Chieri 2
Civitanova Marche 2
Cornate d'Adda 2
Dovera 2
Empoli 2
Eupilio 2
Fabriano 2
Fisciano 2
Fiume Veneto 2
Foggia 2
Fuzhou 2
Giuliano Teatino 2
Gorgonzola 2
Grosseto 2
Grottaminarda 2
Guanzate 2
Totale 854
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 941
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 65
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 62
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 60
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 51
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 48
Middle-Term Outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 46
The sensitivity and positive predictive value (PPV) of I-131-post-therapy whole body scan is higher than serum Tg values in detecting metastases in early stage of differentiated thyroid cancer patients 42
Optimization of radiation shielding of 68Ga sources for positron emission tomography 34
null 23
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 20
Totale 1.392
Categoria #
all - tutte 2.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202043 0 0 0 1 0 12 2 4 3 12 8 1
2020/202144 1 0 20 0 10 0 1 2 4 1 5 0
2021/202284 1 8 0 5 5 1 11 2 1 15 11 24
2022/2023272 21 35 11 13 19 17 11 20 93 16 10 6
2023/2024884 15 32 66 65 59 80 96 122 96 183 70 0
Totale 1.392